Vertex's hepatitis C drug Incivek gains Canadian approval

08/22/2011 | Fox Business

Health Canada approved Incivek, Vertex Pharmaceuticals' treatment for genotype 1 hepatitis C in patients with compensated liver disease. Incivek, taken with ribavirin and pegylated interferon, was clinically proven to achieve a higher viral-cure rate than standard therapy.

View Full Article in:

Fox Business

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN